Matt Husa, MD, is a first year rheumatology fellow. He graduated from Mt. Sinai School of Medicine of New York University after completing the HHMI-NIH Research Scholars Program. His research interests center on chondrocyte biology relating to redox stress and the pathophysiology of osteoarthritis. He is pursuing these interests via full-time research in the laboratory of Robert Terkeltaub, MD, in the Division of Rheumatology, Allergy and Immunology.
Pesu M, Candottie F, Husa M, Hofmann SR, Notarangelo LD, O'Shea JJ. Jak 3, Severe Combined Immunodeficiency, and a New Class of Immunosuppressive Drugs. Immunol Rev. 2005 Feb; 203:127-142.
John J. O'Shea, Matthew Husa, Denise Li, Sigrun R. Hofmann, Wendy Watford, Joseph L. Roberts, Rebecca H. Buckley, Paul Changelian, and Fabio Candotti. Jak3 and the Pathogenesis of Severe Combined Immunodeficiency. Mol Imm. 41 (2004) 727-737.
Sarloos MN, Husa MR, Jackson RS 2nd, Ubels JL. Intermediate filament, laminin and integrin expression in lacrimal gland acinar cells: comparison of an immortalized cell line to primary cells, and their response to retinoic acid. Curr Eye Res. 1999 Nov;19(5):439-49.